The DOI matches its Crossref record; 467 of the 467 references it cites were found in a registry or an index.
Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials
Open accessAbstract
Introduction: The Alzheimer's Disease Neuroimaging Initiative (ADNI) has continued development and standardization of methodologies for biomarkers and has provided an increased depth and breadth of data available to qualified researchers. This review summarizes the over 400 publications using ADNI data during 2014 and 2015. Methods: We used standard searches to find publications using ADNI data. Results: (1) Structural and functional changes, including subtle changes to hippocampal shape and texture, atrophy in areas outside of hippocampus, and disruption to functional networks, are detectable in presymptomatic subjects before hippocampal atrophy; (2) In subjects with abnormal β‐amyloid deposition (Aβ+), biomarkers become abnormal in the order predicted by the amyloid cascade hypothesis; (3) Cognitive decline is more closely linked to tau than Aβ deposition; (4) Cerebrovascular risk factors may interact with Aβ to increase white‐matter (WM) abnormalities which may accelerate Alzheimer's disease (AD) progression in conjunction with tau abnormalities; (5) Different patterns of atrophy are associated with impairment of memory and executive function and may underlie psychiatric symptoms; (6) Structural, functional, and metabolic network connectivities are disrupted as AD progresses. Models of prion‐like spreading of Aβ pathology along WM tracts predict known patterns of cortical Aβ deposition and declines in glucose metabolism; (7) New AD risk and protective gene loci have been identified using biologically informed approaches; (8) Cognitively normal and mild cognitive impairment (MCI) subjects are heterogeneous and include groups typified not only by “classic” AD pathology but also by normal biomarkers, accelerated decline, and suspected non‐Alzheimer's pathology; (9) Selection of subjects at risk of imminent decline on the basis of one or more pathologies improves the power of clinical trials; (10) Sensitivity of cognitive outcome measures to early changes in cognition has been improved and surrogate outcome measures using longitudinal structural magnetic resonance imaging may further reduce clinical trial cost and duration; (11) Advances in machine learning techniques such as neural networks have improved diagnostic and prognostic accuracy especially in challenges involving MCI subjects; and (12) Network connectivity measures and genetic variants show promise in multimodal classification and some classifiers using single modalities are rivaling multimodal classifiers. Discussion: Taken together, these studies fundamentally deepen our understanding of AD progression and its underlying genetic basis, which in turn informs and improves clinical trial design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Self-citationThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Complex brain networks: graph theoretical analysis of structural and functional systems
Bullmore, E., & Sporns, O. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2575 · Cited by 11,820
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152 · cited 1×
“Significant memory concerns Current MCI diagnostic criteria include a significant memory concern (SMC) from either the patient, clinician, or someone close to the patient in addition to quantitative evidence of cognitive impairment with relative preservation of functional abilities [288].”
BackgroundSelf-citationSperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citationHypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Self-citationJack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Self-citationMeta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Self-citationGreicius, M. D., Srivastava, G., Reiss, A. L., & Menon, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308627101 · Cited by 3,684
Research works printed but not linked: 21
- Alexander GE, 2016, A cognitive psychometric model for the psychodiagnostic assessment of memory‐related deficits, Psychol Assess, 28, 279, 10.1037/pas0000163 · doi:10.1037/pas0000163
- Tan M, 2015, Spectral Laplace‐Beltrami wavelets with applications in medical images, IEEE Trans Med Imaging, 34, 1005, 10.1109/TMI.2014.2363884 · doi:10.1109/tmi.2014.2363884
- 10.1002/gps.4179 · doi:10.1002/gps.4179
- 10.1118/1.4923891 · doi:10.1118/1.4923891
- 10.1007/s13534-014-0126-2 · doi:10.1007/s13534-014-0126-2
- Fleishman GM, 2015, Simultaneous Longitudinal Registration with Group‐Wise Similarity Prior, Inf Process Med Imaging, 24, 746
- Gutman B, 2015, A Riemannian Framework for Intrinsic Comparison of Closed Genus‐Zero Shapes, Inf Process Med Imaging, 9123, 205
- Zieselman AL, 2014, Computational genetics analysis of grey matter density in Alzheimer's disease, BioData Min, 7, 17, 10.1186/1756-0381-7-17 · doi:10.1186/1756-0381-7-17
- 10.1002/ana.24420 · doi:10.1002/ana.24420
- 10.1002/ana.24484 · doi:10.1002/ana.24484
- 10.1002/ana.24503 · doi:10.1002/ana.24503
- Hao X, 2014, Identifying genetic associations with MRI‐derived measures via tree‐guided sparse learning, Med Image Comput Comput Assist Interv, 17, 757
- Sheng J, 2014, Data synthesis and method evaluation for brain imaging genetics, Proc IEEE Int Symp Biomed Imaging, 2014, 1202
- 10.1002/gepi.21778 · doi:10.1002/gepi.21778
- Weiss TL, 2015, The role of visualization and 3‐D printing in biological data mining, BioData Min, 8, 22, 10.1186/s13040-015-0056-2 · doi:10.1186/s13040-015-0056-2
- Qi Z, 2014, Multivariate Analysis of structural MRI and PET (FDG and 18F‐AV‐45) for Alzheimer's disease and its prodromal stages, Conf Proc IEEE Eng Med Biol Soc, 2014, 1051
- MoradiE TohkaJ GaserC.Semi‐supervised learning in MCI‐to‐ad conversion prediction—When is unlabeled data useful?Pattern Recognition in Neuroimaging 2014 International Workshop on: IEEE;2014. p.1–4. · doi:10.1109/prni.2014.6858535
- Andrade de Oliveira A, 2015, Defining multivariate normative rules for healthy aging using neuroimaging and machine learning: an application to Alzheimer's disease, J Alzheimers Dis, 43, 201, 10.3233/JAD-140189 · doi:10.3233/jad-140189
- Ranjan P, 2014, Proposal of a new tractographic feature for analysis of white matter in Alzheimer diffusion mr images, Biomed Sci Instrum, 50, 322
- 10.1080/10543406.2014.971173 · doi:10.1080/10543406.2014.971173
- 10.1111/biom.12312 · doi:10.1111/biom.12312
Cited by
Basaia, S., Agosta, F., Wagner, L., Canu, E., Magnani, G., Santangelo, R., & Filippi, M. (2019) · NeuroImage: Clinical · doi:10.1016/j.nicl.2018.101645 · Cited by 738
Veitch, D. P., Weiner, M. W., Aisen, P. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., Morris, J. C., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.08.005 · Cited by 454
Self-citationEl-Sappagh, S., Alonso, J. M., Islam, S. M. R., Sultan, A. M., & Kwak, K. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-82098-3 · Cited by 363
Nho, K., Kueider‐Paisley, A., MahmoudianDehkordi, S., Arnold, M., Risacher, S. L., Louie, G., Blach, C., Baillie, R., Han, X., Kastenmüller, G., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.08.012 · Cited by 343
Self-citationInitiative, F. T. A. D. N., Suárez-Calvet, M., Morenas-Rodríguez, E., Kleinberger, G., Schlepckow, K., Araque Caballero, M. Á., Franzmeier, N., Capell, A., Fellerer, K., Nuscher, B., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0301-5 · Cited by 347
Self-citation
Metadata
- Authors
- Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., Morris, J. C., Petersen, R. C., Saykin, A. J., Shaw, L. M., Toga, A. W., Trojanowski, J. Q., & Initiative, A. D. N.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2017-03-22
- Volume
- 13
- Issue
- 4
- Pages
- e1-e85
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2601368841
- Cited by
- 315
- References
- 467
- FWCI
- 27.30
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- Funders
- National Institute on Aging (P30AG010129, P30AG043097, U01AG024904, R01AG047827, P50 AG005681, P01 AG003991, R01AG048252, R01AG19771, P30AG10133, R44AG049540)
- National Institute of Justice (2014‐R2‐CX‐0012)
- National Institute of Neurological Disorders and Stroke (U54NS079202)
- U.S. Department of Defense (W81XWH‐12‐2‐0012, W81XWH‐13‐1‐0259, W81XWH‐14‐1‐0462)
- Office of Legacy Management (R01LM011360)
- University of Pennsylvania (AG‐010124, NS‐053488)
- Biogen
- Siemens
- AstraZeneca
- Hôpitaux Universitaires de Genève
- Eli Lilly and Company
- University of California
- Pfizer
- Novartis
- Tohoku University
- U.S. Department of Veterans Affairs
- Small Business Innovation Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials. https://app.cochat.ai/papers/10.1016/j.jalz.2016.11.007
- The paper
- Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., Morris, J. C., Petersen, R. C., Saykin, A. J., Shaw, L. M., Toga, A. W., Trojanowski, J. Q., & Initiative, A. D. N. (2017). Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2016.11.007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.